Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. Caring & giving around the globe: 43 Johnson & Johnson programs that are transforming lives—and the future of healthcare
FINAL LEDE- Caring & Giving Around the Globe: 43 Johnson & Johnson Programs That Are Transforming Lives—and the Future of Healthcare- Map story lede collage

Caring & giving around the globe: 43 Johnson & Johnson programs that are transforming lives—and the future of healthcare

Check out this fun interactive map for a glimpse at how the company is helping people on nearly every continent live healthier lives.

Ever since Johnson & Johnson created the world’s first mass-produced sterile surgical sutures in 1887—a game-changing invention that’s still used today—the company has been dedicated to helping improve healthcare around the globe.

It’s actually an imperative outlined in Our Credo—the company mission statement crafted 75 years ago this month that outlines the values Johnson & Johnson uses as its North Star in decision-making, including the belief that consumers, employees and the communities the company serves are all equally important.

And those communities are vast.

Click on this fun interactive map to learn about some of the countries around the world where the company is collaborating with local organizations to support truly life-changing programs—including floating hospitals that travel by sea to reach patients in need.

TEST LEDE- Community Programs around the World- Map 1

Our social impact programs are funded through a variety of entities, including the Johnson & Johnson Foundation, the Johnson & Johnson Corporate Citizenship Trust, Global Community Impact, Global Public Health and the operating companies across our three business segments.

More from Johnson & Johnson

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.

What you need to know about Johnson & Johnson’s fourth-quarter and full-year 2025 earnings report

Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

What is cardiac ablation?

Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.